Skip to content
foodoseGet my numbers
ResearchMental health
Mental healthDisordered eatingSafety

GLP-1s and disordered eating: the question nobody is screening for

A medicine that removes hunger can quiet a difficult relationship with food, or hide one. What specialists have learned from bariatric surgery about symptoms going unnoticed, the signs worth naming out loud, and where to get help that is not about weight.

Published September 2, 20268 min read
4 primary sources citedBy The foodose editorial teamHow we check sources

The 30-second summary

  • These medicines change the relationship with food, not only the appetite. For some people that is the most welcome thing about them. For others it hides a problem that was already there.
  • Almost nobody is screened. Specialists are drawing a direct parallel with the early years of bariatric surgery, when eating disorder symptoms went unrecognised because no standard screening existed.
  • The warning signs are about meaning, not amount. Relief at not eating, fear of appetite returning, eating less than you could manage on purpose.
  • Help exists that is not about weight, and you do not have to be underweight or in crisis to use it.

Why this is being raised now

GLP-1 receptor agonists are being prescribed for weight management on a scale nothing else has reached. What happens when a medicine that removes hunger meets a person whose relationship with food was already complicated is not well studied, and a 2026 paper in the International Journal of Eating Disorders says so plainly: little is known about how these medicines affect people with eating disorders, or about their potential to promote, mask or worsen the psychology behind them.

Lacking direct data, the authors reach for the closest precedent, which is metabolic and bariatric surgery. That history is worth knowing, because it rhymes.

Early in bariatric practice, eating disorder symptoms were underrecognised, because there were no standard screening or monitoring protocols. The first signals were patients saying something was wrong and clinicians noticing. Only later did systematic research follow, and only after that did structured assessment tools and protocols get built. The same shape of concern is now appearing with GLP-1s, where changes in appetite and weight may, without ongoing screening, worsen an existing pattern or contribute to new ones.

The honest summary is that the field is asking a question it cannot yet answer, and saying so early rather than late.

What the medicine does to the relationship, not just the appetite

Most people describe the effect as quiet. The constant negotiation about food, sometimes called food noise, drops away. For someone who has spent twenty years with that noise running, the silence can be the single best thing that has ever happened to them.

That is genuinely good, and it is also why the question is difficult. A medicine that makes eating feel less urgent will look like recovery to someone who has been fighting binge eating, and it will look like permission to someone who has been restricting. The same effect, the same prescription, opposite meanings.

Restriction is the pattern most easily hidden. Eating very little is what the medicine is expected to produce, so eating very little raises no eyebrows. Nobody asks whether you could have eaten more and chose not to. On a GLP-1, the behaviour that would normally attract concern is the behaviour everyone is anticipating.

The signs worth naming

These are not diagnostic. They are the things worth saying out loud to someone.

The meaning has shifted. Not eating starts to feel like an achievement rather than a side effect. A day with less food in it feels like a better day, independent of how you actually felt.

Fear of the appetite returning. Dreading the end of the week before the next dose, not because of physical hunger but because of what hunger means. Wanting a higher dose for the quiet rather than for the result.

Eating less than you could. There is a real difference between cannot and will not, and only you can see it. Turning down food you could have managed, or stopping earlier than the fullness required, is about the relationship.

The number becomes the only measure. Weighing more often than you used to, and the reading setting the tone of the day.

Hiding it. Not mentioning to your prescriber how little you are eating, because you think they will lower the dose. This is the most common one, and the most consequential, because it removes the only person positioned to help.

Old patterns returning in new clothes. Chewing and spitting, purging, laxatives, or compensating for a meal with exercise. If a behaviour you used to do has come back since starting, it has come back.

If any of this is familiar

Tell your prescriber, and be specific. Not "I am not eating much," which they expect, but "I am relieved when I do not eat," which they do not. The second sentence changes the conversation. A history of an eating disorder does not automatically end a prescription, and it does change what should be wrapped around it.

Ask for a referral to someone who treats eating disorders, not someone who treats weight. These are different specialities and the second one cannot substitute for the first.

Do not stop the medicine abruptly on your own if you are worried. Appetite returns, often quite suddenly, and a sudden return of appetite in someone with a restrictive pattern is exactly the situation that goes badly. Stopping is a decision to make with support in place.

Use a helpline before you feel you have earned the right to. You do not need a diagnosis, a low weight, or a crisis. In the UK, Beat runs helplines and online support. In the US, the National Alliance for Eating Disorders runs a helpline staffed by clinicians. Both are free.

If you are supporting someone

Comment on what you notice rather than on their weight or their plate. "You have seemed quite far away at dinner lately" opens a door. "You have not eaten anything" closes one.

Do not make the medicine the villain. For many people it has been the most effective help they have had, and an argument about whether they should be taking it will end the conversation you actually wanted to have.

And be patient with a long silence. People in this position usually know already, and the gap between knowing and saying can be months.

What this site does and does not do

This site calculates a calorie target and a protein floor, and builds days of food to meet them. That is useful when the problem is how to fit enough nutrition into a small appetite.

It is not useful, and may be actively unhelpful, when the problem is the relationship with the numbers themselves. If tracking makes things worse for you, the right move is to stop tracking and speak to someone, and nothing here should persuade you otherwise.

What to do with this

If what you need is a floor to eat up to rather than a ceiling to stay under, that is what the protein number is for: the least you should have, not the most you are allowed.

Find your protein floor

Sources

  1. Herb Neff KM, et al. Eating Disorder Risk and Screening in Patients Using GLP-1RAs: Lessons Learned From Metabolic and Bariatric Surgery. Int J Eat Disord 2026. PubMed
  2. Sievenpiper JL, et al. Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 based therapies: an expert consensus statement using a modified Delphi approach. Obes Pillars 2026. PubMed
  3. Beat. Support services for eating disorders. beateatingdisorders.org.uk
  4. National Alliance for Eating Disorders. Helpline. allianceforeatingdisorders.com

Medical disclaimer: Articles in the foodose research library are educational, not medical advice. Follow the instructions from your prescriber and the leaflet in your pack. See our full medical disclaimer.

Work out your own numbers, not someone else's.

Your calorie target, your protein floor, and the most you can are likely to manage at your dose, with the arithmetic shown. Plus three days of meals. Free, in your browser, nothing stored.

People also ask
Can a GLP-1 cause an eating disorder?
There is no good evidence that the medicine creates one on its own, and there is real concern among specialists that it can mask an existing one or make disordered patterns harder to see. A 2026 paper in the International Journal of Eating Disorders draws the parallel with bariatric surgery, where symptoms went unrecognised for years because nobody was screening.
Should I be screened before starting one?
There is no universal requirement, which is the gap specialists are pointing at. If you have a history of an eating disorder, or a history you have never called that, say so before you start. It does not automatically rule the medicine out, and it changes the support that should come with it.
How do I tell normal appetite loss from something worse?
Appetite loss from the medicine is physical and neutral: you are simply not hungry, and you eat when you remember. Watch instead for the meaning you attach to it. Relief at not eating, fear of appetite returning, or deliberately skipping food you could have managed are about the relationship, not the appetite.
Is it a problem if I feel relieved that I am not hungry?
Relief is a normal first reaction to a quieter head after years of noise, and it is not in itself a warning sign. It becomes one when not eating starts to feel like an achievement, or when eating normally starts to feel like a failure.
Can these medicines help binge eating?
Many people report that the urge to binge falls sharply, and that is one of the most valued effects of the class. It is also why stopping can be difficult, and why the support around the eating needs to exist independently of the prescription.
Where can I get help that is not about weight?
In the UK, Beat runs helplines and online support. In the US, the National Alliance for Eating Disorders runs a clinician-staffed helpline. Both are free, and neither will ask you to justify your weight to qualify.
Written by The foodose editorial team. Published September 2, 2026. Every primary source is checked against its original record before we cite it. How we work.
Keep reading